Literature DB >> 12234807

Cardioprotection by multiple preconditioning cycles does not require mitochondrial K(ATP) channels in pigs.

Lisa M Schwartz1, Timothy S Welch, Mark S Crago.   

Abstract

To test whether cardioprotection induced by ischemic preconditioning depends on the opening of mitochondrial ATP-sensitive K(+) (K(ATP)) channels, the effect of channel blockade was studied in barbital-anesthetized open-chest pigs subjected to 30 min of complete occlusion of the left anterior descending coronary artery and 3 h of reflow. Preconditioning was elicited by two cycles of 5-min occlusion plus 10-min reperfusion before the 30-min occlusion period. 5-Hydroxydecanoate (5 mg/kg iv) was injected 15 min before preconditioning or pharmacological preconditioning induced by diazoxide (3.5 mg/kg, 1 ml/min iv). Infarct size (percentage of the area at risk) after 30 min of ischemia was 35.1 +/- 9.9% (n = 7). Preconditioning markedly limited myocardial infarct size (2.7 +/- 1.6%, n = 7), and 5-hydroxydecanoate did not abolish protection (2.4 +/- 0.9%, n = 8). Diazoxide infusion also significantly limited infarct size (14.6 +/- 7.4%, n = 7), and 5-hydroxydecanoate blocked this effect (30.8 +/- 8.0%, n = 7). Thus the opening of mitochondrial K(ATP) channels is cardioprotective in pigs, but these data do not support the hypothesis that opening of mitochondrial K(ATP) channels is required for the endogenous protection afforded by preconditioning.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234807     DOI: 10.1152/ajpheart.00040.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  12 in total

Review 1.  Mitochondria are sources of metabolic sink and arrhythmias.

Authors:  Fadi G Akar; Brian O'Rourke
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

2.  Activation of ATP-dependent potassium channels is a trigger but not a mediator of ischaemic preconditioning in pigs.

Authors:  Rainer Schulz; Petra Gres; Gerd Heusch
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 3.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 4.  Cardiac mitochondria and arrhythmias.

Authors:  David A Brown; Brian O'Rourke
Journal:  Cardiovasc Res       Date:  2010-07-09       Impact factor: 10.787

Review 5.  Multiplicity of effectors of the cardioprotective agent, diazoxide.

Authors:  William A Coetzee
Journal:  Pharmacol Ther       Date:  2013-06-19       Impact factor: 12.310

6.  Thiazolidinedione drugs promote onset, alter characteristics, and increase mortality of ischemic ventricular fibrillation in pigs.

Authors:  Mohammad Sarraf; Li Lu; Shuyu Ye; Michael J Reiter; Clifford R Greyson; Gregory G Schwartz
Journal:  Cardiovasc Drugs Ther       Date:  2012-06       Impact factor: 3.727

7.  Long-term protection and mechanism of pacing-induced postconditioning in the heart.

Authors:  Fawzi A Babiker; Ilka Lorenzen-Schmidt; Eric Mokelke; Ward Y Vanagt; Tammo Delhaas; Johannes Waltenberger; Jack P Cleutjens; Frits W Prinzen
Journal:  Basic Res Cardiol       Date:  2010-03-25       Impact factor: 17.165

8.  Role of mitochondrial permeability transition pore and mitochondrial ATP-sensitive potassium channels in the protective effects of ischemic preconditioning in isolated hearts from fed and fasted rats.

Authors:  M G Marina Prendes; R Hermann; M E Torresin; D Vélez; E A Savino; A Varela
Journal:  J Physiol Biochem       Date:  2014-07-19       Impact factor: 4.158

9.  Ischemic preconditioning and diazoxide limit mitochondrial Ca overload during ischemia/reperfusion: Role of reactive oxygen species.

Authors:  Matt Eaton; Lisa A Hernandez; Saul Schaefer
Journal:  Exp Clin Cardiol       Date:  2005

10.  Pharmacological preconditioning with diazoxide slows energy metabolism during sustained ischemia.

Authors:  Lisa M Schwartz; Keith A Reimer; Mark S Crago; Robert B Jennings
Journal:  Exp Clin Cardiol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.